US case analysis: Myriad at the Supreme Court

Managing IP Correspondent

August 31 2013

The subject of gene patentability is one of the most controversial topics in life sciences. In June 2013, the US Supreme Court reached a unanimous decision in the Association for Molecular Pathology v Myriad Genetics. It stated that companies cannot patent parts of naturally occurring human genes. Managing IP sat down with Fitzpatrick Cella Harper & Scinto attorneys Robert Fischer, John Carlin and Joshua Rothman to discuss the ruling

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

Managing IP Correspondent

more from across site and SHARED ros bottom lb

More from across our site

Trademarks

This week on MIP: OpenAI discontinues Sora | Nike scores $11m win

News of Dolby suing Snap over AV1 and HEVC patents and SCOTUS offering guidance on the liability of internet service providers were also among the top talking points

Sukanya Sarkar, March 27 2026

Patents

Search new job, finding candidate or discover talent, hiring and recruitment, SEO search engine optimization, find career opportunity concept, business people HR push magnifying glass on search, Gener

Exclusive: CMS IP co-head to join Perkins Coie

Arrival of Caitlin Heard will bolster the soon-to-be-created Ashurst Perkins Coie’s IP presence in the capital

March 27 2026

Patents

Marks & Clerk launches AI practice group with double partner appointment

AI, cybersecurity and data practice group will provide clients with legal guidance around AI alongside a 'deep technical foundation’ in IP

Max Walters, March 26 2026

Patents

Why UPC’s trade secrets ruling could spark a surge of requests

Lawyers at Vondst and Biopatents say a ruling concerning the protected status of trade secrets could see the UPC flooded with requests to prevent access to confidential information

Tom Wittop Koning, March 26 2026

Patents

‘Find answers no one else can’: IP boutique chief on three decades in IP

Sharad Vadehra of Kan & Krishme discusses why older IP firms still have an edge over up-and-coming boutiques and how the firm is using AI to provide quick and cost-effective service

Sukanya Sarkar, March 26 2026

Patents

Big pile of oranges with green leaves lies. Citrus fruits are fresh and juicy. Many mandarins at market

Freshly squeezed: how Appleyard Lees secured mandarin PVR win

Lawyers at Appleyard Lees share how they picked apart a plant breeder’s infringement claims concerning the ‘Tango’ mandarin

March 26 2026

Patents

An open treasure chest emits a luminous golden mist and sparkles into darkness

UPC update: When trade secrets become open | Abbott files claim

A further decision on long-arm status, and a new hire for Pentarc in Germany from Taylor Wessing were also among top developments

March 26 2026

Patents

Baker Botts leads Netflix to victory in fraudulent patent transfer claim

The US decision marks a rare grant of a request under the Uniform Fraudulent Transfer Act in a patent case

Sukanya Sarkar, March 25 2026

Trademarks

IP law firm contempt of court battle heats up

Stobbs has applied to strike out a contempt of court application filed against the firm and two of its lawyers

Max Walters, March 25 2026

Trademarks

Agentic ai workflow artificial intelligence technology automation glowing data stream merges with digital gears futuristic creative concept

From reactive clearance to AI-powered brand intelligence

With trademark volumes surging, trademark teams need to think beyond traditional clearance searches, towards a continuous, intelligence-led workflow, says Meghan Medeiros of Corsearch

Meghan Medeiros, March 25 2026